Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by JPPOUGET
Group name EquipeJPP
Item Type Journal Article
Title Hepatobiliary Scintigraphy and Glass 90Y Radioembolization with Personalized Dosimetry: Dynamic Changes in Treated and Nontreated Liver
Creator Allimant et al.
Author Carole Allimant
Author Emmanuel Deshayes
Author Marilyne Kafrouni
Author Lore Santoro
Author Marjolaine Fourcade
Author Christophe Cassinotto
Author Margaux Hermida
Author Chloé Guillot
Author Denis Mariano-Goulart
Author Boris Guiu
Abstract Background: The functional changes that occur over time in the liver following 90Y-radioembolization (RE) using personalized dosimetry (PD) remain to be investigated. Methods: November 2016 - October 2019: we retrospectively included hepatocellular carcinoma (HCC) patients treated by 90Y-glass RE using PD, who underwent hepatobiliary scintigraphy (HBS) at baseline and at 15 days, 1, 2, 3, and 6 months after RE. Results: There were 16 patients with unilobar disease (100%) included, and 64 HBS were performed. Whole liver function significantly decreased over time. The loss was maximal at 2 weeks: ?32% (p = 0.002) and remained below baseline at 1 (?15%; p = 0.002), 2 (?25%; p < 0.001), and 3 months (?16%; p = 0.027). No radioembolization-induced liver disease was observed. Treated liver function strongly decreased to reach ?64% (p < 0.001) at 2 months. Nontreated liver function decreased at 2 weeks (?21%; p = 0.027) and remained below baseline before reaching +20% (p = 0.002) and +59% (p < 0.001) at 3 and 6 months, respectively. Volumetric and functional changes exhibited parallel evolutions in the treated livers (p = 0.01) but independent evolutions in the nontreated livers (p = 0.08). Conclusion: RE using PD induces significant regional changes in liver function over time. As early as 15 days following RE, both the treated and nontreated livers showed a decreased function. Nontreated liver function recovered after 3 months and greatly increased afterwards.
Publication Diagnostics
Volume 11
Issue 6
Pages 931
Date 2021-05-21
Journal Abbr Diagnostics
Language en
DOI 10.3390/diagnostics11060931
ISSN 2075-4418
Short Title Hepatobiliary Scintigraphy and Glass 90Y Radioembolization with Personalized Dosimetry
URL https://www.mdpi.com/2075-4418/11/6/931
Accessed 2023/11/23 - 12:22:14
Library Catalog DOI.org (Crossref)
Extra Number: 6
Tags clinic, hepatobiliary scintigraphy, mebrofenin, selective internal radiation therapy
Date Added 2023/11/23 - 12:44:41
Date Modified 2024/12/15 - 11:27:16
Notes and Attachments Full Text (Attachment)
Full Text (Attachment)
Full Text (Attachment)
Full Text (Attachment)
Full Text (Attachment)
Full Text (Attachment)
PubMed entry (Attachment)
PubMed entry (Attachment)
PubMed entry (Attachment)
PubMed entry (Attachment)
PubMed entry (Attachment)
PubMed entry (Attachment)
Texte intégral (Attachment)


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés